DiaCarta's Series B Round

DiaCarta raised a round of funding on November 20, 2017.

DiaCarta (帝基生物) is a translational genomics and personalized diagnostics company. DiaCarta is dedicated to the science of rapid, highly sensitive detection technologies and diagnostic solution…

Articles about DiaCarta's Series B Round: